Compare MDGL & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | KD |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | 80000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 2.6B |
| IPO Year | 2005 | 2021 |
| Metric | MDGL | KD |
|---|---|---|
| Price | $396.52 | $15.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 6 |
| Target Price | ★ $688.78 | $17.40 |
| AVG Volume (30 Days) | 519.5K | ★ 3.9M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $180,133,000.00 | ★ $15,092,000,000.00 |
| Revenue This Year | $65.40 | N/A |
| Revenue Next Year | $37.87 | N/A |
| P/E Ratio | ★ N/A | $797.50 |
| Revenue Growth | N/A | ★ 0.23 |
| 52 Week Low | $353.54 | $10.10 |
| 52 Week High | $615.00 | $27.84 |
| Indicator | MDGL | KD |
|---|---|---|
| Relative Strength Index (RSI) | 30.84 | 50.76 |
| Support Level | $353.54 | $11.44 |
| Resistance Level | $553.95 | $17.71 |
| Average True Range (ATR) | 26.18 | 0.94 |
| MACD | 0.67 | -0.15 |
| Stochastic Oscillator | 32.02 | 46.02 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.